Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1677-2018Class II

Immulite /Immulite 1000 Br-Ma (Ca15-3)

Siemens Healthcare Diagnostics Inc. / initiated 2018-01-02 / Terminated / root cause: labeling and UDI

Siemens Healthcare Diagnostics, Inc. began a recall of IMMULITE /IMMULITE 1000 BR-MA (CA15-3) on . FDA classified it as Class II and gives the reason as "Concentrations for the level of biotin that does not interfere is not currently listed in the instruction for use for the Dimension Vista CTNI, Dimension Vista MMB, Dimension Sirolimus, ADVIA Centaur FOL, ADVIA Centaur...". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-1677-2018
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Siemens Healthcare Diagnostics Inc.
Product
Immulite /Immulite 1000 Br-Ma (Ca15-3)
Product code
MOI System, Test, Immunological, Antigen, Tumor
Reason for recall
Concentrations for the level of biotin that does not interfere is not currently listed in the instruction for use for the Dimension Vista CTNI, Dimension Vista MMB, Dimension Sirolimus, ADVIA Centaur FOL, ADVIA Centaur aHBcM and the following IMMULITE assays, 3gAllergy Specific IgE, anti-HBc, BR-MA (CA15-3), CEA, Folic Acid, Gastrin, OM-MA (CA125), Thyroglobulin, and Vitamin B12, and these assays are susceptible to interference from biotin.
Root cause tag
labeling and UDI
FDA root cause
Error in labeling
Action
Siemens Healthcare Diagnostics issued a recall in March 2017 for products with incorrect units for biotin in the Instructions for Use. After further investigation, recalling firm determined that more Siemens products also had missing or incorrect information in the IFUs for which two recalls were initiated, and Amended Corrections and Removals Reports were submitted to the FDA
Distribution
Nationwide and Canada, Mexico, and Thailand
Product codes and lots
BR-MA/CA15-3, BR-MA/CA15-3 (IMMULITE/IMMULITE 1000, LKBR1), (IMMULITE 2000/IMMULITE 2000 XPi, LKBR2)  Lot codes: 0312 0313

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1677-2018
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1668-2018Class IITerminatedVoluntary: Firm initiated
Z-1669-2018Class IITerminatedVoluntary: Firm initiated
Z-1670-2018Class IITerminatedVoluntary: Firm initiated
Z-1671-2018Class IITerminatedVoluntary: Firm initiated
Z-1672-2018Class IITerminatedVoluntary: Firm initiated
Z-1673-2018Class IITerminatedVoluntary: Firm initiated
Z-1674-2018Class IITerminatedVoluntary: Firm initiated
Z-1675-2018Class IITerminatedVoluntary: Firm initiated
Z-1676-2018Class IITerminatedVoluntary: Firm initiated
Z-1677-2018Class IITerminatedVoluntary: Firm initiated
Z-1678-2018Class IITerminatedVoluntary: Firm initiated
Z-1679-2018Class IITerminatedVoluntary: Firm initiated
Z-1680-2018Class IITerminatedVoluntary: Firm initiated
Z-1681-2018Class IITerminatedVoluntary: Firm initiated
Z-1682-2018Class IITerminatedVoluntary: Firm initiated
Z-1683-2018Class IITerminatedVoluntary: Firm initiated
Z-1684-2018Class IITerminatedVoluntary: Firm initiated
Z-1685-2018Class IITerminatedVoluntary: Firm initiated
Z-1686-2018Class IITerminatedVoluntary: Firm initiated
Z-1687-2018Class IITerminatedVoluntary: Firm initiated
Z-1688-2018Class IITerminatedVoluntary: Firm initiated
Z-1689-2018Class IITerminatedVoluntary: Firm initiated
Z-1690-2018Class IITerminatedVoluntary: Firm initiated
Z-1691-2018Class IITerminatedVoluntary: Firm initiated